Imago BioSciences (NASDAQ:IMGO) Downgraded by Zacks Investment Research to Sell

Imago BioSciences} stock has undergone multiple analysts rating changes in the recent past.  Imago BioSciences Downgraded by Zacks Investment Research on 10/20/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More Imago BioSciences (NASDAQ:IMGO) Downgraded by Zacks Investment Research to Sell